ObsEva Reports Second Quarter 2017 Financial Results And Provides Business Update Post author:Sam Post published:August 15, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Life Science Community Comes Together to Support Rare Disease Day February 27, 2018 Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience December 13, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017